
Sign up to save your podcasts
Or


Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
By John Simboli5
77 ratings
Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.

3,063 Listeners

1,986 Listeners

1,094 Listeners

2,338 Listeners

945 Listeners

796 Listeners

126 Listeners

337 Listeners

6,135 Listeners

90 Listeners

10,205 Listeners

564 Listeners

151 Listeners

248 Listeners

188 Listeners